ArticleLife science alliance2019
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.
Christopher R Heier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it